- Home
- ORIS vs ISPC Comparison
ORIS vs ISPC Comparison
Compare ORIS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- ISPC
- Stock Information
- Founded
- ORIS 2014
- ISPC 2009
- Country
- ORIS China
- ISPC United States
- Employees
- ORIS N/A
- ISPC 24
- Industry
- ORIS Farming/Seeds/Milling
- ISPC Precision Instruments
- Sector
- ORIS Consumer Staples
- ISPC Health Care
- Exchange
- ORIS Nasdaq
- ISPC Nasdaq
- Market Cap
- ORIS 5.3M
- ISPC 5.7M
- IPO Year
- ORIS 2024
- ISPC 2021
- Fundamental
- Price
- ORIS $0.13
- ISPC $0.54
- Analyst Decision
- ORIS
- ISPC
- Analyst Count
- ORIS 0
- ISPC 0
- Target Price
- ORIS N/A
- ISPC N/A
- AVG Volume (30 Days)
- ORIS 16.2M
- ISPC 216.8K
- Earning Date
- ORIS 01-01-0001
- ISPC 11-17-2025
- Dividend Yield
- ORIS N/A
- ISPC N/A
- EPS Growth
- ORIS N/A
- ISPC N/A
- EPS
- ORIS 0.17
- ISPC N/A
- Revenue
- ORIS $15,014,000.00
- ISPC $3,352,744.00
- Revenue This Year
- ORIS N/A
- ISPC $35.93
- Revenue Next Year
- ORIS N/A
- ISPC N/A
- P/E Ratio
- ORIS $0.71
- ISPC N/A
- Revenue Growth
- ORIS N/A
- ISPC N/A
- 52 Week Low
- ORIS $0.08
- ISPC $0.53
- 52 Week High
- ORIS $56.01
- ISPC $4.90
- Technical
- Relative Strength Index (RSI)
- ORIS 43.81
- ISPC 31.72
- Support Level
- ORIS $0.11
- ISPC $0.56
- Resistance Level
- ORIS $0.16
- ISPC $0.67
- Average True Range (ATR)
- ORIS 0.02
- ISPC 0.06
- MACD
- ORIS -0.00
- ISPC 0.00
- Stochastic Oscillator
- ORIS 14.02
- ISPC 16.94
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.